Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill shows promise against lung cancer in early trial

NCT ID NCT03807778

Ongoing Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen May 16, 2026 · Last updated May 16, 2026

Summary

This study tests an oral drug called Mobocertinib in Japanese adults with non-small cell lung cancer. In the first part, different groups receive increasing doses to find the safest amount. In the second part, participants get that best dose to see if their tumors shrink. The goal is to control the disease, not cure it, as ongoing treatment is needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aichi Cancer Center Hospital

    Nagoya, Aichi-ken, Japan

  • Cancer Institute Hospital

    Koto-ku, Tokyo, Japan

  • Fujita Health University Hospital

    Toyoake, Aichi-ken, Japan

  • Hiroshima University Hospital

    Hiroshima, Japan

  • Hokkaido Cancer Center

    Sapporo, Hokkaido, Japan

  • Hyogo Cancer Cente

    Akashi, Hyōgo, Japan

  • Kanagawa Cancer Center

    Yokohama, Kanagawa, Japan

  • Kanazawa University Hospital

    Kanazawa, Ishikawa-ken, Japan

  • Kansai Medical University Hospital

    Hirakata, Osaka, Japan

  • Kindai University Hospital

    Sayama, Osaka, Japan

  • Kurume University Hospital

    Kurume, Fukuoka, Japan

  • Kyoto University Hospital

    Kyoto, Japan

  • Kyushu University Hospital

    Fukuoka, Japan

  • National Cancer Center Hospital

    Chuo-ku, Tokyo, Japan

  • National Cancer Center Hospital East

    Kashiwa, Chiba, Japan

  • National Hospital Organization Kinki-Chuo Chest Medical Center

    Sakai, Osaka, Japan

  • Niigata Cancer Center Hospital

    Niigata, Japan

  • Okayama University Hospital

    Kita-ku, Okayama-ken, Japan

  • Osaka International Cancer Institute

    Osaka, Japan

  • Saitama Cancer Center

    Shinden, Saitama, Japan

  • Sendai Kousei Hospital

    Sendai, Miyagi, Japan

  • Tokushima University Hospital

    Tokushima, Japan

  • Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

    Bunkyo-ku, Tokyo, Japan

  • Wakayama Medical University Hospital

    Wakayama, Japan

  • Yamaguchi Ube Medical Center

    Ube, Yamaguchi, Japan

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CANCER